ARTICLE | Company News
EC approves J&J's Xeplion
March 10, 2011 1:39 AM UTC
The European Commission approved an MAA for Xeplion paliperidone palmitate from Johnson & Johnson (NYSE:JNJ) for the maintenance treatment of schizophrenia in adult patients stabilized with paliperido...